Onconetix (ONCO) Announces 1:85 Reverse Share Split

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/28/2026

1. ORCL
2. AVGO
3. BA
4. CDNS
5. ANT
6. SPY
7. META
8. HOOD
9. STX
10. INTC

Go back to Onconetix (ONCO) Announces 1:85 Reverse Share Split

Onconetix, Inc. Announces 1-for-85 Reverse Stock Split and Results of the Special Meeting of Stockholders

June 11, 2025 11:30 AM EDT

CINCINNATI, Ohio, June 11, 2025 (GLOBE NEWSWIRE) -- Onconetix, Inc. (NASDAQ: ONCO) (Onconetix or the Company), a commercial-stage biotechnology company focused on the research, development, and commercialization of innovative solutions for mens health and oncology, today announced that the Companys stockholders have approved a proposal to effect a reverse split, which was voted on at the Companys 2025 special meeting of stockholders (the Special Meeting) held on May 30, 2025, and that its Board of Directors (the Board of Directors or Board) approved a 1-for-85 reverse stock split of its outstanding shares of common stock, to be... More